Saddoughi, Sahar A. et al
"Results of a Phase II Trial of Gemcitabine Plus Doxorubicin in Patients with Recurrent Head and Neck Cancers: Serum C18-Ceramide as a Novel Biomarker for Monitoring Response." Clinical Cancer Research
17.18
(2011):
6097-6105.
Web. 20 Jan. 2021.
